Metropolitan Life Insurance Company (MetLife)’s Transmedics TMDX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,650	Closed	-$122K	–	1927
2024 Q1	$122K	Sell	1,650 -179	-10%	-$14.8K	0.01%	950
2023 Q4	$144K	Hold	1,829	–	–	0.01%	900
2023 Q3	$100K	Buy	1,829 +96	+6%	+$6.91K	0.01%	1009
2023 Q2	$146K	Buy	+1,733	New	+$133K	0.01%	822
2023 Q1	–	Sell	-1,840	Closed	-$114K	–	2459
2022 Q4	$114K	Hold	1,840	–	–	0.01%	982
2022 Q3	$76.8K	Hold	1,840	–	–	﹤0.01%	1173
2022 Q2	$57.9K	Hold	1,840	–	–	﹤0.01%	1409
2022 Q1	$49.6K	Sell	1,840 -6,307	-77%	-$113K	﹤0.01%	1594
2021 Q4	$156K	Hold	8,147	–	–	﹤0.01%	2198
2021 Q3	$270K	Buy	+8,147	New	+$249K	﹤0.01%	1864
2021 Q2	–	Sell	-7,698	Closed	-$319K	–	2875
2021 Q1	$319K	Sell	7,698 -407	-5%	-$12.5K	﹤0.01%	1710
2020 Q4	$161K	Hold	8,105	–	–	﹤0.01%	2083
2020 Q3	$112K	Buy	8,105 +2,110	+35%	+$36.1K	﹤0.01%	2154
2020 Q2	$107K	Buy	5,995 +720	+14%	+$11.3K	﹤0.01%	2217
2020 Q1	$63.7K	Hold	5,275	–	–	﹤0.01%	2297
2019 Q4	$100K	Buy	+5,275	New	+$96.9K	﹤0.01%	2331

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TMDX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Transmedics (TMDX) in Q2 2024, closing a stake of 1,650 shares — an estimated $122K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TMDX in Q4 2019 and held it in 16 quarters. The position peaked at $319K in Q1 2021. 340 funds tracked by Wall St. Rank hold TMDX as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Transmedics position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,650 Transmedics shares in Q2 2024, an estimated $122K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Transmedics in Q4 2019 and held it in 16 quarters.
Metropolitan Life Insurance Company (MetLife)'s Transmedics position peaked at $319K in Q1 2021.
340 funds tracked by Wall St. Rank held Transmedics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.